Concepedia

A-C. Madroszyk Flandin

AM

Statistics

Publications

2

Citations

20

H-Index

2

Active since

2022

Affiliations

Centre Antoine Lacassagne(Current)

Intergroupe Francophone de Cancérologie Thoracique

Centre Hospitalier Universitaire de Grenoble

Institut Paoli-Calmettes

Assistance Publique – Hôpitaux de Paris

A-C. Madroszyk Flandin is an author at Centre Antoine Lacassagne.

Publications per year

2022–2024

2

Publications

2

972O Nivolumab (Nivo) plus ipilimumab (Ipi) 6-months treatment versus continuation in patients with advanced non-small cell lung cancer (aNSCLC): Results of the randomized IFCT-1701 phase III trial

Gérard Zalcman, A-C. Madroszyk Flandin, Olivier Molinier et al. · Annals of Oncology · 2022 · 10 citations

1259MO Encorafenib plus binimetinib in patients (pts) with previously untreated BRAF V600E-mutant advanced non-small cell lung cancer (NSCLC): An open-label, multicenter phase II trial (IFCT-1904 ENCO-BRAF)

David Planchard, J. Mazieres, C. Mascaux et al. · Annals of Oncology · 2024 · 10 citations

Rows per page

1–2 of 2